APA (7th ed.) Citation

A, H., ST, A., O, E., JW, H., S, K., K, R., . . . CA, S. (2023). Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 29(12), 1587. https://doi.org/10.1016/j.cmi.2023.08.026

Chicago Style (17th ed.) Citation

A, Huttner, et al. "Antibody Responses to Recombinant Vesicular Stomatitis Virus-Zaire Ebolavirus Vaccination for Ebola Virus Disease Across Doses and Continents: 5-year Durability." Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 29, no. 12 (2023): 1587. https://doi.org/10.1016/j.cmi.2023.08.026.

MLA (9th ed.) Citation

A, Huttner, et al. "Antibody Responses to Recombinant Vesicular Stomatitis Virus-Zaire Ebolavirus Vaccination for Ebola Virus Disease Across Doses and Continents: 5-year Durability." Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 29, no. 12, 2023, p. 1587, https://doi.org/10.1016/j.cmi.2023.08.026.